TYW1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.951400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.919400E-01
Normal-vs-Stage2
4.229000E-01
Normal-vs-Stage3
8.648400E-01
Normal-vs-Stage4
1.528010E-01
Stage1-vs-Stage2
6.873400E-01
Stage1-vs-Stage3
6.733000E-01
Stage1-vs-Stage4
2.155400E-01
Stage2-vs-Stage3
4.446200E-01
Stage2-vs-Stage4
2.172600E-01
Stage3-vs-Stage4
1.470410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.001400E-01
Normal-vs-AfricanAmerican
1.999590E-01
Normal-vs-Asian
8.432200E-01
Caucasian-vs-AfricanAmerican
7.825900E-02
Caucasian-vs-Asian
6.297600E-02
AfricanAmerican-vs-Asian
7.694200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.491800E-01
Normal-vs-Female
3.451400E-01
Male-vs-Female
4.871400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.811200E-01
Normal-vs-Age(41-60Yrs)
2.293400E-01
Normal-vs-Age(61-80Yrs)
4.551000E-01
Normal-vs-Age(81-100Yrs)
8.372800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.971200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.114600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.972960E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.663610E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.215700E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.479500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.192600E-01
Normal-vs-Daily Drinker
4.320000E-01
Normal-vs-Weekly Drinker
8.900400E-01
Normal-vs-Occasional Drinker
3.178000E-01
Normal-vs-Social Drinker
1.796000E-01
Non Drinker-vs-Daily Drinker
8.771000E-01
Non Drinker-vs-Weekly Drinker
1.714230E-01
Non Drinker-vs-Occasional Drinker
2.053000E-01
Non Drinker-vs-Social Drinker
2.572400E-01
Daily Drinker-vs-Weekly Drinker
1.780370E-01
Daily Drinker-vs-Occasional Drinker
2.626800E-01
Daily Drinker-vs-Social Drinker
3.798600E-01
Weekly Drinker-vs-Occasional Drinker
3.881700E-02
Weekly Drinker-vs-Social Drinker
2.480200E-02
Occasional Drinker-vs-Social Drinker
6.415200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.296800E-01
Normal-vs-Grade 2
3.416800E-01
Normal-vs-Grade 3
3.472800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.846000E-01
Grade 1-vs-Grade 3
2.430800E-01
Grade 1-vs-Grade 4
3.296800E-01
Grade 2-vs-Grade 3
4.324400E-01
Grade 2-vs-Grade 4
3.416800E-01
Grade 3-vs-Grade 4
3.472800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.491200E-01
Normal-vs-NonDiabetic
4.045800E-01
Diabetic-vs-NonDiabetic
4.854800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.522600E-01
Normal-vs-NoPancreatitis
4.352600E-01
Pancreatitis-vs-NoPancreatitis
6.175000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.127800E-01
Normal-vs-N1
3.992200E-01
N0-vs-N1
7.892400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.189200E-01
Normal-vs-TP53-NonMutant
1.964010E-01
TP53-Mutant-vs-TP53-NonMutant
1.082810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
